Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Can quantitative sensory testing predict treatment outcomes in hip and knee osteoarthritis? A systematic review and meta-analysis of individual participant data
Murphy, Myles , Mosler, A. , Coventry, Molly , Arendt‐Nielsen, Lars , Bjurström, Martin F. , Larsen, Dennis Boye , Olesen, Anne Estrup , Hertel, Emma , Holm, Pætur Mikal , Gomes, Cid André Fidelis de Paula , Drewes, Asbjørn Mohr , Nunes, Guilherme S. , Østerås, Håvard , Öztürk, Özgul , Pozsgai, M. , Rasmussen, Sten , Rice, David A. , Romero, Eleuterio A. Sánchez , Irani, Anushka, Stausholm, Martin Bjørn , Petersen, Kristian Kjær , Irani, Anushka , Murphy, Myles C , Irani, Anushka , Rio, Ebonie , Raj, Isaac Selva , Chivers, Paola , Alfieri, Fábio Marcon , Chang, Wei‐Ju , Graven‐Nielsen, Thomas , Henriksen, Marius , Klinedinst, N. Jennifer , Mathew, Jerin , O’Leary, Helen , Rampazo, Érika Patrícia , Irani, Anushka, Hince, Dana

Pain | May 1, 2025 | Volume: 166 | Issue: 10 | Pages: 2261-2280

10.1097/j.pain.0000000000003627 | PMID 40310871 Get It

Abstract An individual participant data (IPD) meta-analysis can assess the predictive value of data on outcomes at the individual level, offering a potential tool for developing personalized pain management. Pretreatment quantitative sensory testing (QST) may stratify patient groups, which are then linked to treatment outcomes. Our objective was to determine if measures of QST at baseline are related to treatment outcomes (at any time point) for pain and disability in lower-limb osteoarthritis. We performed a systematic review with an IPD meta-analysis. Searches were conducted in 9 databases until May 5, 2023 for intervention studies that measured baseline QST and longitudinal measures of participant-reported pain and disability. We performed a 2-stage approach to analyse longitudinal data. Individual models were fitted to each study and combined using random effects multivariate meta-analytic models. Study quality was assessed using the Joanna Briggs Institute checklist, and certainty of the evidence was assessed using GRADE. We identified 3082 records and included 1 hip and 28 knee datasets consisting of 2522 participants from 40 studies. Local warm detection thresholds (P = 0.024) predicted knee osteoarthritis pain outcomes (very-low certainty). Local warm detection thresholds (P = 0.030), remote cold detection thresholds (P = 0.05), and remote pressure tolerance thresholds (P = 0.007) predicted knee osteoarthritis disability outcomes (very-low certainty). Other QST variables were associated with hip and knee osteoarthritis pain and disability levels (eg, pressure pain thresholds), but this relationship did not change over time. This review finds that mechanism-based, QST methodologies do not consistently predict pain or disability on an individual level in hip or knee osteoarthritis.
Synthetic Feature Augmentation Improves Generalization Performance of Language Models
Salehinejad, Hojjat , Choudhary, Ashok, Thiels, Cornelius A.

2025 IEEE Symposium on Computational Intelligence in Natural Language Processing and Social Media (CI-NLPSoMe Companion) | May 1, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-5

10.1109/ci-nlpsomecompanion65206.2025.10977896 Get It

The Future of Robotics in Plastic and Reconstructive Surgery
Payne, Camryn, Martinez, Casey , Spronsen, Nicole Van , Shrout, Max A., Morris, Bryn E., Casey, William J., Rhee, Daniel H. , Reece, Edward, Yi, Johnny , Rebecca, Alanna M. , Payne, Cynthia S. , Van Spronsen, Nicole, Shrout, Max, Casey, William, Rhee, Daniel, Rebecca, Alanna, Payne, Camryn S , Payne, Camryn, Jungbauer, Walter N

Annals of Plastic Surgery | May 1, 2025 | Volume: 94 | Issue: 5S | Pages: S421-S424

10.1097/sap.0000000000004278 | PMID 40310003 Get It

Abstract Robots have been used effectively in plastic and reconstructive surgery (PRS) for reconstruction. The utilization of robotics in all surgical specialties is expanding with the goal of offering the most appropriate patient-centered care possible, especially in complex multidisciplinary cases. Despite the safety, efficiency, and reproducibility of robotics in PRS, there is a paucity of required and formalized training in PRS residency programs. The ACGME and industry published guidelines were investigated. Robotic surgery case logs of Mayo Clinic Arizona General Surgery residents were analyzed with attention to equivalency certification (EQ). Over the past 5 years, the equivalency certification from Intuitive (Sunnyvale, CA) was obtained by 30% of all general surgery residents at our institution (range, 0–100). The case numbers to obtain the equivalence certification are industry recommendations, and proficiency is determined by the program director. The ACGME does not mandate robotics training in general surgery residency. According to the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), trainees must complete 20 console cases and 10 bedside cases to become industry certified. With respect to training and advancing the field, PRS residents could successfully obtain certification in their residency programs. The minimum case requirement recommended by SAGES is not burdensome and can ensure robotic privileges in PRS practice immediately following graduation. By improving the training for minimally invasive robotic surgery in plastic surgery, patients and healthcare systems benefit from improved quality of life outcomes and decreased postoperative length of stay, which results in less strain on our entire medical system.
HOPE Experience Essentials: The Next Generation of Service Standards at Mayo Clinic
Packard, Jennifer, Welch, Thomas, Munson, Karee, Leighton, Jonathan A. , Packard, Jennifer, Eliáš, Richard

Patient Experience Journal | May 1, 2025 | Volume: 12 | Issue: 1 | Pages: 192-197

10.35680/2372-0247.1907 Get It

Engaging employees in providing exemplary patient experience has been challenging for healthcare leaders in recent years given the pressures of the regulatory environment, increases in staff burnout and rising patient expectations. Amid these challenges, addressing patient experience remains a top priority for healthcare organizations. A novel intervention has been applied at Mayo Clinic with the goal of improving both employee engagement and patient experience. Previous efforts to teach service excellence involved customer service trainings, sometimes purchased through outside vendors. This new initiative is based on our organizational culture and values, input from our employees and patients, and considers the changing needs of a contemporary healthcare workforce. It leverages management practices shown to boost an employee's sense of equity, achievement, and camaraderie. It also highlights staff motivation to do their best work by involving them in conversations about the essential ingredients that make up both exceptional employee and patient experiences.
Regional Anesthesia for Pain Management in Idiopathic Multicentric Osteolysis: A Case Report
Elsea, Katherine B., VanderWielen, Beth A.

A&A Practice | May 1, 2025 | Volume: 19 | Issue: 5 | Pages: e01966

10.1213/xaa.0000000000001966 | PMID 40310081 Get It

Idiopathic multicentric osteolysis (IMO) is a rare disease characterized by rapid spontaneous bone loss, typically affecting the carpal and tarsal bones. Patients with IMO often suffer from chronic pain, immobility, and renal disease, posing challenges for pain control in the perioperative setting. We present the case of a 19-year-old woman with Gorham-Stout syndrome, a subtype of IMO, who underwent a successful femoral nerve block and catheter placement under general anesthesia for palliative knee resection. This case report illustrates the safety and efficacy of regional anesthesia for postoperative pain control, emphasizing its potential benefits in this unique patient population.
Genome‐wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease
Hou, Xu , Fiesel, Fabienne C. , White, Launia J. , Quicksall, Zachary , Reddy, Joseph S. , Ross, Owen A. , Valentino, Rebecca R. , Ross, Owen A , Fiesel, Fabienne C , Hou, Xu , Heckman, Michael G. , Koga, Shunsuke , Soto‐Beasley, Alexandra I. , Watzlawik, Jens O. , Zhao, Jing , Johnson, Patrick W. , Brás, José , Guerreiro, Rita , Zhao, Na , Bu, Guojun , Dickson, Dennis W. , Springer, Wolfdieter

Alzheimer's & Dementia | May 1, 2025 | Volume: 21 | Issue: 4 | Pages: No page available

10.1002/alz.70198 | PMID 40309932 Get It

AbstractINTRODUCTIONPhosphorylated ubiquitin (p‐S65‐Ub) is generated during PINK1‐PRKN mitophagy as a specific marker of mitochondrial damage. Despite the widespread deposition of p‐S65‐Ub in aged and diseased human brain, the genetic contribution to its accumulation remains unclear.METHODSTo identify novel mitophagy regulators, we performed a genome‐wide association study using p‐S65‐Ub level as a quantitative trait in 1012 autopsy‐confirmed Lewy body disease (LBD) samples.RESULTSWe identified a significant genome‐wide association with p‐S65‐Ub for rs429358 (apolipoprotein E ε4 [APOE4]) and a suggestive association for rs6480922 (ZMIZ1). APOE4 was associated with higher p‐S65‐Ub levels and greater neuropathological burden. Functional validation in mouse and human induced pluripotent stem cell (iPSC) models confirmed APOE4‐mediated mitophagy alterations. Intriguingly, ZMIZ1 rs6480922 was associated with lower p‐S65‐Ub levels, reduced neuropathological load, and increased brain weight, indicating a potential protective role.DISCUSSIONOur findings underscore the importance of mitochondrial quality control in LBD pathogenesis and nominate regulators that may contribute to disease risk or resilience.Highlights p‐S65‐Ub levels were used as a quantitative marker of mitochondrial damage. A GWAS identified two genetic variants that modify mitophagy in LBD autopsy brain. APOE4 was associated with increased p‐S65‐Ub accumulation and neuropathology. APOE4 altered mitophagy via pathology‐dependent and pathology‐independent mechanisms. ZMIZ1 was linked to reduced p‐S65‐Ub and neuropathology indicative of protection.
A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network
Boghean, Lidia , Singh, Sarbjit , Mangalaparthi, Kiran K. , Kizhake, Smitha , Umeta, Lelisse T. , Grothaus, Paul G., Pandey, Akhilesh , Natarajan, Amarnath , Pandey, Akhilesh , Natarajan, Amarnath , Wishka, Donn G.

Molecules | May 1, 2025 | Volume: 30 | Issue: 9 | Pages: 2001

10.3390/molecules30092001 | PMID 40363807 Get It

The quinoxaline core is found in several biologically active compounds, with Erdafitinib being the first FDA-approved quinoxaline derivative that targets a kinase and exhibits anti-cancer properties. We previously reported a quinoxaline analog (84) that displayed anti-cancer effects by inhibiting IKKβ, a key kinase in the NFκB pathway. Here, we present the synthesis of a regioisomer (51-106) and its characterization as a selective MAP3K1 inhibitor with improved metabolic stability and oral bioavailability. We used the small molecule MAP3K1 inhibitor in a proteomics study that identified NPM1 as a member of the MAP3K1 network.
Introduction. Advances in spine tumor management: innovations in surgery, radiation, and biomarkers
Bilsky, Mark H. , Moraes, Fábio Ynoe de , Goodwin, C. Rory , Lubelski, Daniel , Clarke, Michelle J.

Neurosurgical Focus | May 1, 2025 | Volume: 58 | Issue: 5 | Pages: E1

10.3171/2025.2.focus24672 Get It

Impact of surgery and radiation on radicular pain and myotomic weakness in patients with metastatic spine disease
Bartolozzi, Arthur R. , Laufer, Ilya , Sahgal, Arjun , Rhines, Laurence D. , Sciubba, Daniel M. , Weber, Michael H. , Schuster, James M. , Gokaslan, Ziya L. , Fisher, Charles G. , Dea, Nicolas, Bartolozzi, Arthur R., Barzilai, Ori , Lazáry, Áron , Boriani, Stefano , Bettegowda, Chetan , Arnold, Paul M. , Clarke, Michelle J. , Fehlings, Michael G. , Bilsky, Mark H. , Dea, Nicolas

Neurosurgical Focus | May 1, 2025 | Volume: 58 | Issue: 5 | Pages: E14

10.3171/2025.2.focus24915 | PMID 40311205 Get It

OBJECTIVE Surgery is typically indicated for mechanical pain in metastatic spine disease or severe neurological compromise, but how radicular pain responds to oncological treatment is not well described. The primary aim of this study was to describe how radicular pain responds to oncological treatment, while secondary aims included pain outcomes between patients with mechanical and tumoral pain and motor improvement in patients with weakness due to nerve root compression. METHODS Patients treated with surgery and/or radiotherapy for spinal metastases were identified from an international multicenter prospective cohort. The primary outcome was the numeric rating scale (NRS) score for pain at 3 months posttreatment. Motor recovery from radicular compression in patients with myotomic weakness and low-grade epidural compression was also analyzed. RESULTS Of 284 patients, 129 (45%) had radicular pain ± axial pain and 155 (55%) had axial pain alone. The two groups did not significantly differ in age, comorbidities, tumor characteristics, or treatment. Two hundred two patients (71%) underwent surgery ± radiotherapy, whereas 82 (29%) had radiotherapy alone. The NRS score of patients with radicular pain improved from 6.7 to 3.4 at 3 months, a statistically significantly higher magnitude than in patients with isolated axial pain (p = 0.021). The NRS score at 3 months was similar for both groups (p = 0.876). Patients with radicular pain experienced a larger improvement with surgery compared with radiotherapy alone (p = 0.007) but had higher pretreatment pain (mean NRS score 7.0 vs 5.6, p = 0.013). Twenty-three patients identified with radicular/myotomic weakness (mean American Spinal Injury Association score 96.3 ± 3.2) at baseline improved 2.1 ± 3.8 points at 3 months. CONCLUSIONS The magnitude of pain improvement for patients with radicular pain following surgery and radiotherapy for metastatic spine disease is higher than for patients with axial pain alone. Surgery is associated with a larger improvement in radicular pain than radiotherapy alone. These results will allow clinicians to tailor treatment options for patients with metastatic spine disease.
Risk factors for early pathological fracture following stereotactic body radiation therapy for spinal metastases
Capp, Juliana C., Pennington, Zach , Mikula, Anthony L. , Lakomkin, Nikita , Sebastian, Arjun S. , Freedman, Brett A. , Rose, Peter S. , Karim, S. Mohammed, Bydon, Mohamad , Krauss, William E. , Fogelson, Jeremy L. , Merrell, Kenneth W. , Elder, Benjamin D. , Pennington, Zach , Capp, Juliana C., Hamouda, Abdelrahman M. , Freedman, Brett A. , Nassr, Ahmad , Kowalchuk, Roman O. , Clarke, Michelle J.

Neurosurgical Focus | May 1, 2025 | Volume: 58 | Issue: 5 | Pages: E13

10.3171/2025.2.focus24905 | PMID 40311209 Get It

OBJECTIVE The aim of this study was to determine independent risk factors for vertebral compression fracture (VCF) following stereotactic body radiation therapy (SBRT) in metastatic spine disease. METHODS Patients treated with SBRT for spinal metastasis at a single tertiary care center between 2008 and 2019 were retrospectively identified. Patients with CT scans obtained within 1 year of SBRT completion were included. Variables collected included demographics, Spine Instability Neoplastic Score (SINS), primary tumor pathology, Weinstein-Boriani-Biagini (WBB) classification, chemoradiation treatment details, and bone quality as assessed by Hounsfield units (HUs) on CT. HUs were measured for the medullary bone of the metastatic level, the tumor, and the vertebral bodies cephalad and caudal to the metastasis. Multivariable logistic regression was used to identify predictors of post-SBRT pathological fracture. RESULTS A total of 292 patients (mean age 66 years) with 392 unique lesions were included. The most common pathologies were prostate (n = 193), kidney/renal cell (n = 46), and lung (n = 33). The most common tumor levels were thoracic (n = 206 lesions) and lumbar (n = 128 lesions). SBRT was generally delivered in 1–3 fractions with doses ranging from 16 to 24 Gy in 1 fraction and 24–36 Gy in 3 fractions. Of the 392 lesions, 73 suffered VCF: 21 (29%) with < 25% height loss, 15 (21%) with 25%–40% height loss, and 37 (51%) with > 40% height loss. On univariate analysis, patients with VCF had lower average HUs (156 ± 52 vs 202 ± 89, p < 0.001), more WBB sectors involved (3 ± 2 vs 3 ± 1, p < 0.001), higher SINSs (8 ± 3 vs 6 ± 2, p < 0.001), were more commonly female (33% vs 22%, p = 0.05), and more commonly had nonprostate pathology (67% vs 47%, p = 0.003). VCF rates were similar between moderate (< 20 Gy in 1 fraction, < 30 Gy in 3 or 5 fractions) and high-dose (> 20 Gy in 1 fraction, > 30 Gy in 3 or 5 fractions) radiation schema (15% VCF vs 16% no VCF, respectively; p = 0.99). On multivariable logistic regression, independently significant predictors of VCF were HUs ≤ 229 (OR 6, p < 0.001), affected levels ≥ 3 WBB segments (OR 3, p < 0.001), and an SINS ≥ 8 (OR 2, p = 0.02). CONCLUSIONS Low pre-radiation HUs, involvement of more WBB sectors, and a higher SINS were independent predictors of VCF following SBRT for metastatic spine disease.